financetom
Business
financetom
/
Business
/
ConocoPhillips to Sell Anadarko Basin Assets for $1.3 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ConocoPhillips to Sell Anadarko Basin Assets for $1.3 Billion
Aug 7, 2025 11:30 AM

02:07 PM EDT, 08/07/2025 (MT Newswires) -- ConocoPhillips ( COP ) said in a regulatory filing Thursday that it agreed to sell its assets in the Anadarko Basin for about $1.3 billion, subject to standard closing adjustments.

The deal, which was signed in July, is expected to close in early Q4, the company said.

The company said that the sale pushes it past its original $2 billion asset sale target ahead of schedule.

The energy producer also reported Thursday Q2 adjusted earnings and revenue that beat analyst expectations.

Shares of ConocoPhillips ( COP ) were 1% up in recent trading activity.

Price: 94.08, Change: +0.97, Percent Change: +1.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arch Capital Q4 Operating Income Falls, Revenue Rises
Arch Capital Q4 Operating Income Falls, Revenue Rises
Feb 10, 2025
04:18 PM EST, 02/10/2025 (MT Newswires) -- Arch Capital Group ( ACGL ) late Monday reported Q4 after-tax operating income of $2.26 per diluted share compared with $2.49 a year earlier. Analysts polled by FactSet expected $1.81. Net premiums written for the quarter ended Dec. 31 was $3.82 billion, compared with $3.26 billion a year earlier. Analysts expected $4.02 billion....
Iovance Biotherapeutics Shares Fell Today: What's Going On?
Iovance Biotherapeutics Shares Fell Today: What's Going On?
Feb 10, 2025
Iovance Biotherapeutics Inc. ( IOVA ) shares closed lower on Monday as the company announced Dan Kirby as Chief Commercial Officer. What To Know: The move comes as Iovance aims to strengthen its commercial strategy amid the U.S. launch of Amtagvi and the expansion of Proleukin. Kirby brings extensive experience in commercializing cell therapy products, having previously led market access,...
Coty misses quarterly revenue estimates on slowing demand for cosmetics
Coty misses quarterly revenue estimates on slowing demand for cosmetics
Feb 10, 2025
Feb 10 (Reuters) - Coty ( COTY ) cut its annual profit forecast on Monday after missing second-quarter revenue estimates on Monday, as it grapples with slowing demand for cosmetics in the United States and a tighter control of beauty inventory by retailers. Coty's ( COTY ) results come shortly after those of Elf Beauty and L'Oreal, which have flagged...
Astera Labs Q4 Non-GAAP Net Income, Revenue Increase; Q1 Outlook Set -- Shares Drop
Astera Labs Q4 Non-GAAP Net Income, Revenue Increase; Q1 Outlook Set -- Shares Drop
Feb 10, 2025
04:20 PM EST, 02/10/2025 (MT Newswires) -- Astera Labs ( ALAB ) reported Q4 non-GAAP net income late Monday of $0.37 per diluted share, up from $0.12 a year ago. Analysts polled by FactSet expected $0.26. Revenue for the quarter ended Dec. 31 was $141.1 million, up from $50.5 million a year earlier. Analysts expected $127.9 million. For Q1, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved